India to Congo Pharmaceutical Export (2026) — $19.0M, 101 Suppliers | TransData Nexus

India to Congo Pharmaceutical Export (2026) — $19.0M, 101 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Congo

#	Formulation	Value	Share
1	Lumiter Dt Ps: 30x12sbno:nad2345d Md.02/23 Ed.01/26	$10.3M	54.5%
2	Lumiter Dt Bno:nad2345b Md.02/23 Ed.01/26 Ps: 30x6s	$303.3K	1.6%
3	Pharmaceutical Goods Luther (1x6 Tablets)	$185.4K	1.0%
4	Harmless Medicines:- Artemether 80mg/ml	$168.1K	0.9%
5	Aleze Ec B	$148.8K	0.8%
6	(1x1+4)b#nr01730a Mfg. Date: Dec-2023 Exp. Date: Nov-2025	$145.4K	0.8%
7	Isoniazid 300mg / Rifapentine 300mg Tablets Bno:nie2351b Mfg.dt.sep-2023 Exp.dt…	$142.5K	0.8%
8	Rifampicin 150mg Isoniazid 75mg Tablets Each Carton of 24x28 Tablets	$142.2K	0.7%
9	Ophthalmic Medicaments Dexamethasone Eye	$136.6K	0.7%
10	Ophthalmic Medicaments Ofloxacin 0.3%+ D	$136.6K	0.7%
11	Ophthalmic Medicaments Naphazoline Hydro	$136.6K	0.7%
12	Aleze Ec (1x1) B.no. Nr01879a, Nr01880b, Nr01881amft. Dt: Apr-2024 Exp. Dt: Mar…	$135.4K	0.7%
13	Harmless Pharma Medicines Finished Formquinine Di Hydrochloride BP Injection 50…	$134.7K	0.7%
14	Aleze Ec Batch No- Nr01666b, Nr01668a, Nr01669a Mgf Date-nov-2023 Exp Date - Oc…	$129.3K	0.7%
15	Isoniazid 300mg / Rifapentine 300mg Tablets (9000 Pac X 3 X 12s) Drugs and Phar…	$128.3K	0.7%

India exports 20+ pharmaceutical formulations to Congo with a combined trade value of $19.0M. Key products include Artemether ($10.3M), Isoniazid ($143K), Rifampicin ($142K), Dexamethasone ($137K), Ofloxacin ($137K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,100 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Congo Trade Routes

1Artemether$10.3M

2Isoniazid$143K

3Rifampicin$142K

4Dexamethasone$137K

5Ofloxacin$137K

Top Indian Exporters to Congo

1Macleods Pharmaceuticals Ltd

$10.9M

2Naari Pharma Private Limited

$1.3M

3Appasamy Associates Private Limited

$1.2M

4Alliaance Biotech

$528K

5Asons Pharmaceuticals Private Limited

$491K

Port Analysis — India to Congo Pharmaceutical Shipments

Indian Export Ports

BANGALORE AIR6.0%

CHENNAI AIR5.0%

DELHI AIR10.0%

MUNDRA SEA6.3%

MODINAGAR ICD0.5%

Congo Import Ports

Matadi11.6%

LUMBUMBASHI10.7%

MATADI6.4%

KINSHASA18.8%

BRAZZAVILLE11.5%

Trade Statistics

Total Value$19.0M

Shipments1,100

Indian Exporters101

Congo Buyers102

Avg Shipment$17K

Products851

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Congo Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and the Democratic Republic of Congo (DRC) has experienced significant growth over the past decade. In 2024, India exported pharmaceutical products worth approximately $149.98 million to Congo, marking a substantial increase from previous years. This surge reflects India's expanding role as a key supplier of essential medicines to the African continent. The trade encompasses a diverse range of pharmaceutical formulations, including tablets, capsules, syrups, and injections, catering to Congo's healthcare needs.

Key milestones in this bilateral trade include the establishment of direct shipping routes and the implementation of favorable trade policies. Notably, in June 2020, the DRC government suspended import duties on medical products and pharmaceutical equipment for six months, aiming to enhance the availability of essential medicines. This policy shift facilitated smoother trade flows and underscored the strategic importance of pharmaceutical imports from India.

2India's Market Position

India holds a significant position in Congo's pharmaceutical import landscape. In 2024, India exported pharmaceutical products valued at $149.98 million to Congo, contributing to a total import value of $156.37 million for that year. This indicates that Indian pharmaceutical exports constitute approximately 95% of Congo's total pharmaceutical imports, highlighting India's dominant role in supplying Congo's pharmaceutical market. The strategic importance of this trade is further emphasized by the diverse range of products exported, which align with Congo's healthcare requirements.

Congo Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in the DRC must adhere to the guidelines set by the Congolese Pharmaceutical Regulatory Authority (ACOREP). The registration process involves submitting a comprehensive dossier that includes product information, manufacturing details, and quality control measures. While Good Manufacturing Practice (GMP) certification is officially required, enforcement is often inconsistent; a Certificate of Pharmaceutical Product (CPP) is a critical document. The timeline for registration can vary, but ACOREP aims to provide a decision on clinical trial applications within 30 days of submission, following ethics committee approval.

2GMP & Facility Requirements

ACOREP mandates that pharmaceutical products imported into the DRC comply with GMP standards. Manufacturing facilities in India must demonstrate adherence to these standards, which are evaluated through inspections and the submission of relevant certifications. While GMP certification is officially required, enforcement is often inconsistent; a Certificate of Pharmaceutical Product (CPP) is a critical document. The inspection process involves a thorough review of manufacturing practices, quality control measures, and facility conditions to ensure compliance with Congolese regulations.

3Import Documentation

To import pharmaceutical products into the DRC, Indian exporters must provide several key documents:

Certificate of Pharmaceutical Product (CPP): This document certifies that the product is authorized for sale in the country of origin and complies with international standards.

Certificate of Analysis (CoA): This certificate provides detailed information on the product's composition and quality, ensuring it meets the required specifications.

GMP Certificate: This certificate attests that the manufacturing facility adheres to GMP standards, ensuring the product's quality and safety.

Additionally, importers must secure an import license from an authorized commercial bank and undergo a pre-shipment inspection by Bureau Veritas for shipments valued over $500,000. Customs procedures require the submission of these documents for clearance, and compliance with labeling rules, including the use of French on all documentation, is mandatory. Non-compliance can lead to significant sanctions, including product recalls and fines.

TransData Nexus Research · Congo regulatory databasesMar 2026

FAQ — India to Congo Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Congo?

India exported pharmaceuticals worth $19.0M to Congo across 1,100 verified shipments.

Who are the top Indian pharmaceutical exporters to Congo?

1. MACLEODS PHARMACEUTICALS LTD — $10.9M. 2. NAARI PHARMA PRIVATE LIMITED — $1.3M. 3. APPASAMY ASSOCIATES PRIVATE LIMITED — $1.2M. Total: 101 suppliers.

Which companies in Congo import pharmaceuticals from India?

1. SECRETARIAT GENERAL DE LA SANTE — $10.7M. 2. LAmbassade de lOrdre Souverain — $1.2M. 3. DKT INTERNATIONAL RD CONGO — $1.2M. 102 buyers total.

What pharmaceutical products does India export most to Congo?

1. Lumiter Dt Ps: 30x12sbno:nad2345d Md.02/23 Ed.01/26 ($10.3M, 54.5%); 2. Lumiter Dt Bno:nad2345b Md.02/23 Ed.01/26 Ps: 30x6s ($303.3K, 1.6%); 3. Pharmaceutical Goods Luther (1x6 Tablets) ($185.4K, 1.0%); 4. Harmless Medicines:- Artemether 80mg/ml ($168.1K, 0.9%); 5. Aleze Ec B ($148.8K, 0.8%)

Which ports handle pharmaceutical shipments from India to Congo?

Export: BANGALORE AIR, CHENNAI AIR, DELHI AIR, MUNDRA SEA, MODINAGAR ICD. Import: Matadi, LUMBUMBASHI, MATADI, KINSHASA, BRAZZAVILLE.

Why does Congo import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $19.0M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Congo?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Congo pharmaceutical trade?

$17.3K per consignment across 1,100 shipments.

How many Indian pharmaceutical companies export to Congo?

101 Indian companies. Largest: MACLEODS PHARMACEUTICALS LTD with $10.9M.

How can I find verified Indian pharmaceutical suppliers for Congo?

TransData Nexus covers 101 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Congo identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,100 verified shipments from 101 Indian exporters to 102 Congo buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

101 Exporters

102 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Congo Pharmaceutical Export

Top Pharmaceutical Formulations — India to Congo

Top Pharmaceutical Products — India to Congo Trade Routes

Top Indian Exporters to Congo

Port Analysis — India to Congo Pharmaceutical Shipments

Indian Export Ports

Congo Import Ports

Trade Statistics

Other Destinations

India–Congo Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Top Congo Buyers from India

Product Routes

Full Dataset Access

3Recent Developments

Congo Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Congo

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Congo

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Congo Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance